Preliminary report by Sanchez-Cerrillo et al. (56) suggested that preferential migration of CD1c+ DC (DC2) to the lungs, could be associated with dysregulation of CD8+T cell activation and poor prognosis for COVID-19 patients. This evidence concerns the gene CD1C and COVID-19.